Development of an I-metaiodobenzylguanidine Myocardial Three-Dimensional Quantification Method for the Diagnosis of Lewy Body Disease

Overview

Journal Asia Ocean J Nucl Med Biol

Specialty Nuclear Medicine

Date 2018 Jul 13

PMID 29998146

Citations 1

Authors

Yoshito Kamiya

Satoru Ota

Yuta Tanaka

Kosuke Yamashita

Akihiro Takaki

Shigeki Ito

Affiliations

Soon will be listed here.

Abstract

Objectives: We recently developed a new uptake index method for I-metaiodobenzylguanidine (I-MIBG) heart uptake measurements by using planar images (radioisotope angiography and planar image) for the diagnosis of Lewy body disease (LBD), including Parkinson's disease (PD) and dementia with Lewy bodies (DLB). However, the diagnostic accuracy of the uptake index was approximately equal to that of the heart-to-mediastinum ratio (H/M) for the discrimination of the LBD and non-LBD patients. A simple and pain-free uptake index method using I-MIBG SPECT images by modifying the uptake index method may show better diagnostic accuracy than the planar uptake index method. We hypothesized that the development of a new uptake index method for the determination of I-MIBG using single-photon emission computed tomography (SPECT) imaging would provide a reliable and reproducible diagnostic tool for clinical application. Regarding this, the purpose of this study was to develop a new uptake index method with a simple protocol to determine I-MIBG uptake on SPECT.

Methods: The I-MIBG input function was determined from the input counts of the pulmonary artery, assessed by analyzing the pulmonary artery time-activity curves. The I-MIBG output function was obtained from I-MIBG SPECT counts on the polar map. The uptake index was calculated through dividing the output function by the input function (SPECT uptake method). For the purpose of the study, 77 patients underwent I-MIBG SPECT, with an average of 31.5 min after clinical assessment and injection of the tracer. The H/M values, as well as planar and SPECT uptake indices were calculated, and then correlated with clinical features.

Results: According to the results, values obtained for LBD were significantly lower than those for non-LBD in all analyses (P<0.01). The overlap of the H/M values between the LBD and non-LBD cases ranged from 2.06 to 2.50. Furthermore, the overlap in uptake index values between LBD and non-LBD cases in planar image analysis was 1.05-1.29. The SPECT uptake index method showed the least overlap of 1.23-1.25, with the highest value for LBD patients clearly distinguished from the lowest value for the non-LBD patients.

Conclusion: The new I-MIBG SPECT quantification method, developed by the input counts of the pulmonary artery, clearly distinguished LBD from non-LBD. Therefore, this method may be appropriate for routine clinical study.

Citing Articles

The utility of heart-to-mediastinum ratio using a planar image created from IQ-SPECT with Iodine-123 meta-iodobenzylguanidine.

Shibutani T, Nakajima K, Yoneyama H, Konishi T, Okuda K, Onoguchi M J Nucl Cardiol. 2020; 28(6):2569-2577.

PMID: 32103408 DOI: 10.1007/s12350-020-02081-9.

References

Patil H, Bateman T, McGhie A, Burgett E, Courter S, Case J . Diagnostic accuracy of high-resolution attenuation-corrected Anger-camera SPECT in the detection of coronary artery disease. J Nucl Cardiol. 2013; 21(1):127-34. DOI: 10.1007/s12350-013-9817-9. View

van der Veen B, Al Younis I, de Roos A, Stokkel M . Assessment of global cardiac I-123 MIBG uptake and washout using volumetric quantification of SPECT acquisitions. J Nucl Cardiol. 2012; 19(4):752-62. PMC: 3395351. DOI: 10.1007/s12350-012-9539-4. View

El Fakhri G, Buvat I, Benali H, Todd-Pokropek A, Di Paola R . Relative impact of scatter, collimator response, attenuation, and finite spatial resolution corrections in cardiac SPECT. J Nucl Med. 2000; 41(8):1400-8. View

Nakajima K, Okuda K, Yoshimura M, Matsuo S, Wakabayashi H, Imanishi Y . Multicenter cross-calibration of I-123 metaiodobenzylguanidine heart-to-mediastinum ratios to overcome camera-collimator variations. J Nucl Cardiol. 2014; 21(5):970-8. PMC: 4167440. DOI: 10.1007/s12350-014-9916-2. View

Ofuji A, Mimura H, Yamashita K, Takaki A, Sone T, Ito S . Development of a simple non-invasive microsphere quantification method for cerebral blood flow using I-123-IMP. Ann Nucl Med. 2016; 30(3):242-9. DOI: 10.1007/s12149-015-1053-8. View

Yamashita K, Uchiyama Y, Ofuji A, Mimura H, Okumiya S, Takaki A . Fully automatic input function determination program for simple noninvasive (123)I-IMP microsphere cerebral blood flow quantification method. Phys Med. 2016; 32(9):1180-5. DOI: 10.1016/j.ejmp.2016.08.021. View

Kamiya Y, Ota S, Okumiya S, Yamashita K, Takaki A, Ito S . Uptake Index of I-metaiodobenzylguanidine Myocardial Scintigraphy for Diagnosing Lewy Body Disease. Asia Ocean J Nucl Med Biol. 2017; 5(1):37-43. PMC: 5221684. DOI: 10.22038/aojnmb.2016.7972. View

Nakajima K, Matsumoto N, Kasai T, Matsuo S, Kiso K, Okuda K . Normal values and standardization of parameters in nuclear cardiology: Japanese Society of Nuclear Medicine working group database. Ann Nucl Med. 2016; 30(3):188-99. PMC: 4819542. DOI: 10.1007/s12149-016-1065-z. View

Masunaga S, Uchiyama Y, Ofuji A, Nagaoka R, Tomimatsu T, Iwata A . Development of an automatic ROI setting program for input function determination in 99mTc-ECD non-invasive cerebral blood flow quantification. Phys Med. 2014; 30(4):513-20. DOI: 10.1016/j.ejmp.2014.01.004. View

10.

Okuda K, Nakajima K, Hosoya T, Ishikawa T, Konishi T, Matsubara K . Semi-automated algorithm for calculating heart-to-mediastinum ratio in cardiac Iodine-123 MIBG imaging. J Nucl Cardiol. 2010; 18(1):82-9. DOI: 10.1007/s12350-010-9313-4. View

11.

Nakajima K, Yoshita M, Matsuo S, Taki J, Kinuya S . Iodine-123-MIBG sympathetic imaging in Lewy-body diseases and related movement disorders. Q J Nucl Med Mol Imaging. 2008; 52(4):378-87. View

12.

Chen J, Folks R, Verdes L, Manatunga D, Jacobson A, Garcia E . Quantitative I-123 mIBG SPECT in differentiating abnormal and normal mIBG myocardial uptake. J Nucl Cardiol. 2011; 19(1):92-9. DOI: 10.1007/s12350-011-9438-0. View

13.

HOEHN M, Yahr M . Parkinsonism: onset, progression, and mortality. 1967. Neurology. 2002; 57(10 Suppl 3):S11-26. View

14.

Merlet P, Valette H, Dubois-Rande J, Moyse D, Duboc D, Dove P . Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med. 1992; 33(4):471-7. View

15.

Metz C, Herman B, Shen J . Maximum likelihood estimation of receiver operating characteristic (ROC) curves from continuously-distributed data. Stat Med. 1998; 17(9):1033-53. DOI: 10.1002/(sici)1097-0258(19980515)17:9<1033::aid-sim784>3.0.co;2-z. View

16.

Taki J, Yoshita M, Yamada M, Tonami N . Significance of 123I-MIBG scintigraphy as a pathophysiological indicator in the assessment of Parkinson's disease and related disorders: it can be a specific marker for Lewy body disease. Ann Nucl Med. 2004; 18(6):453-61. DOI: 10.1007/BF02984560. View

17.

Dorfman D, Berbaum K, Metz C . Receiver operating characteristic rating analysis. Generalization to the population of readers and patients with the jackknife method. Invest Radiol. 1992; 27(9):723-31. View

18.

King A, Mintz J, Royall D . Meta-analysis of 123I-MIBG cardiac scintigraphy for the diagnosis of Lewy body-related disorders. Mov Disord. 2011; 26(7):1218-24. DOI: 10.1002/mds.23659. View

19.

Giorgetti A, Burchielli S, Positano V, Kovalski G, Quaranta A, Genovesi D . Dynamic 3D analysis of myocardial sympathetic innervation: an experimental study using 123I-MIBG and a CZT camera. J Nucl Med. 2015; 56(3):464-9. DOI: 10.2967/jnumed.114.143669. View

20.

Mu X, Hasegawa S, YOSHIOKA J, Maruyama A, Maruyama K, Paul A . Clinical value of lung uptake of iodine-123 metaiodobenzylguanidine (MIBG), a myocardial sympathetic nerve imaging agent, in patients with chronic heart failure. Ann Nucl Med. 2002; 15(5):411-6. DOI: 10.1007/BF02988344. View